1Revillion F, Bonneterre J. ErbB2 oucogene in human breast cancer and its clinical significance[J]. Eur Jcancer, 1998, 34 (6) : 791.
2Meden H, Marx D, Roegglen T, et al. Ovevexpression of the oucogene C- erbB2 (HER2/neu) and response to chemotherapy in patients with ovarian cancer[J]. Int J. Gynecol Pathol, 1998, 17(1): 61.
3Kumar R, Yarmand-Bagheri R. The role of HER2 in anglogenesis[J]. Semin Oncol, 2001, 28(5 suppl 16) : 27.
9Fehrn T, Gebauer G, Jager W, et al. Clinical utility of serial serum C-erbB2 determinations in the follow up of breast[J]. cancer patients. Breast Cancer Res Treat, 2002, 75(2 ): 97.
1YAMASAKI L,PAGANO M.Cell cycle,proteolysis and cancer[J].Curr Opin Cell Biol,2004,16(6):623-628.
2LIN D I,DIEHL J A.Mechanism of cell-cycle control:ligating the ligase[J].Trends Biochem Sci,2004,29(9):453-455.
3BLOOM J,PAGANO M.Deregulated degradation of the cdk inhibitor p27 and malignant transformation[J].Semin Cancer Biol,2003,13 (1):41-47.
4SHIBATA H,MATSUBARA O,WAKIYAMA H,et al.The role of cyclin-dependent kinase inhibitor p27 in squamous cell carcinoma of the esophagus[J].Pathol Res Pract,2001,197 (3):157-164.
5NAKAYAMA K,NAGAHAMA H,MINAMISHIMA Y A,et al.Skp2-mediated degradation of p27 regulates progression into mitosis[J].Dev Cell,2004,6(5):661-672.
6O'HAGAN R C,OHH M,DAVID G,et al.Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression[J].Genes Dev,2001,14(17):2185-2191.
7Bouras, Frauman A G. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancer: a biphasic relationship with tumor grade[J]. Journal of Pathology, 1999, 188(4): 382.
8Guo X Z, Friess H, Di Mola F F, et al. KAI1, a new metastasis suppressor gene, is reduced in metastasis hepatocellular carcinoma[J]. Hapatology, 1998, 28(6): 1481.
9Dong J T, Isaacs W B, Barrett J C, et al. Genomic organization of the human KAI1 metastasis suppressor gene[J]. Genomics, 1997, 41: 25.
10Uchida S, Shimada Y, Watanabe G, et al. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma[J]. Br J Cancer, 1999, 79(7～8): 1168.
2Graf T, Beug H. Avian leukemia viruses interaction with their target cells in vivo and in vitro [J]. Biochem Biophys Acta,1978,516 (3) :269.
3Schechter A L, Stern D F, Vaidyanathan I, et al. The new oncogene: an erb-B-related gene encoding a 185,000-Mrtumour antigen [J]. Nature, 1984, 312(10) :513.
4Plowman G D, Whitney G S, Neubauer M G, et al. Molecular cloning and expression of an additional epidermal growth factor receptor-related gene [J]. Proc Natl Acad Sci USA, 1990,87 (13) : 4905-4909.
5Plowman G D, Culouscou J M, Whitney G S, et al. Ligand-specific activation of HER4/P180 a fourth member of the epidermal growth factor receptor family [J]. Proc Nail Acad Sci USA, 1993,90(5) : 1746-1750.
6Nishigaki H, Wada K, Tatsuguehi A, et al. ErbB2 without erbB3 expression in metaplastic columnar epithelium of Barrett's esophagus [J]. Digestion,2004,70(2) : 95-102.
7Xu S, Kitayama J, Yamashita H, et al. Nuclear translocation of HER-4/c-erbB-4 is significantly correlated with prognosis of esophageal squamous cell carcinoma [J ]. J Surg Oncol, 2008,97 ( 10) : 44-50.
8Szentpali K, Szell M, Paszt A, et al. Simultaneous adeno-and squamous cell carcinoma with different phenotypic profiles in a rat model of chronic gastroesophageal reflux [J]. Dis Esophagus, 2007, 20(6) :305-310.
9Kawaura Y, Tatsuzawa Y, Wakabayashi T, et al. Immunohistochemical study of p53, c-erbB-2, and PCNA in Barrett's esophagus with adenocarcinoma arising from experimental acid or alkaline reflux model [J]. J Gastroenterol,2001,36(7): 595-600.
